Internet-based cognitive testing in multiple sclerosis

Abstract

Cognitive impairment in multiple sclerosis is difficult to study because of the heterogeneity and variability of this disease. The gold standard for measurement of cognitive function in multiple sclerosis is a full battery of neurocognitive tests, which is time consuming and expensive. Some cognitive tests like the PASAT, a measure of working verbal memory and processing speed, have been proposed for screening and follow-up of cognitive function in clinical trials. We studied whether we could measure cognitive function in multiple sclerosis over the Internet. For this we used the Cognitive Stability Index (CSI)™, developed for persons with known or suspected primary central nervous system illness. The CSI was compared with formal neurocognitive testing (NPsych) and the PASAT in a cross-sectional study of 40 consecutive multiple sclerosis patients with subjective cognitive complaints. NPsych revealed that only 18 of the 40 patients (46%) were cognitively impaired. Although both the CSI and the PASAT were equalivalent in their specificity (86%), the CSI was significantly more sensitive than the PASAT (83% versus 28%). We conclude that the CSI, because of its availability over the Internet, has great potential as a tool for screening and follow up of cognitive function in multiple sclerosis. Multiple Sclerosis 2007; 13: 1011—1019. http://msj.sagepub.com

Keywords

cognitive function depression Internet multiple sclerosis PASAT screening

Get full access to this article

View all access options for this article.

References

Bagert B. , Camplair P. , Bourdette D. Cognitive dysfunction in multiple sclerosis: natural history, pathophysiology and management. CNS Drugs 2002; 16: 445—55.

DeSousa EA , Albert RH , Kalman B. Cognitive impairments in multiple sclerosis: a review. Am J Alzheimers Dis Other Demen 2002; 17: 23—29.

Bobholz JA , Rao SM Cognitive dysfunction in multiple sclerosis: a review of recent developments . Curr Opin Neurol 2003; 16: 283—88.

Christodoulou C. , Krupp LB , Liang Z. , Huang W. , Melville P. , Roque C. et al. Cognitive performance and MR markers of cerebral injury in cognitively impaired MS patients. Neurology 2003; 60: 1793—98.

Rao SM , St Aubin-Faubert P, Leo GJ. Information processing speed in patients with multiple sclerosis. J Clin Exp Neuropsychol 1989; 11: 471—77.

van den Burg W. , van Zomeren AH , Minderhoud JM , Prange AJ , Meijer NS Cognitive impairment in patients with multiple sclerosis and mild physical disability. Arch Neurol 1987; 44: 494—501.

Sartori E. , Edan G. Assessment of cognitive dysfunction in multiple sclerosis. J Neurol Sci 2006; 245: 169—75.

Fontaine B. , Seilhean D. , Tourbah A. , Daumas-Duport C. , Duyckaerts C. , Benoit N. et al. Dementia in two histologically confirmed cases of multiple sclerosis: one case with isolated dementia and one case associated with psychiatric symptoms . J Neurol Neurosurg Psychiatry 1994; 57: 353—59.

Filley CM , Heaton RK , Nelson LM , Burks JS , Franklin GM A comparison of dementia in Alzheimer's disease and multiple sclerosis. Arch Neurol 1989; 46: 157—61.

10.

Fisk JD , Archibald CJ Limitations of the Paced Auditory Serial Addition Test as a measure of working memory in patients with multiple sclerosis. J Int Neuropsychol Soc 2001; 7: 363—72.

11.

Rudick RA , Cutter G. , Baier M. , Fisher E. , Dougherty D. , Weinstock-Guttman B. et al. Use of the multiple sclerosis functional composite to predict disability in relapsing MS. Neurology 2001 ; 56: 1324—30.

12.

Fischer JS , Priore RL , Jacobs LD , Cookfair DL , Rudick RA , Herndon RM et al. Neuropsychological effects of interferon beta-1a in relapsing multiple sclerosis. Multiple Sclerosis Collaborative Research Group. Ann Neurol 2000; 48: 885—92.

13.

Aupperle RL , Beatty WW, Shelton Fde N, Gontkovsky ST. Three screening batteries to detect cognitive impairment in multiple sclerosis. Mult Scler 2002; 8: 382—89.

14.

Benedict RH , Cox D. , Thompson LL , Foley F. , Weinstock-Guttman B. , Munschauer F. Reliable screening for neuropsychological impairment in multiple sclerosis. Mult Scler 2004; 10: 675—78.

15.

Erlanger DM , Kaushik T. , Broshek D. , Freeman J. , Feldman D. , Festa J. Development and validation of a web-based screening tool for monitoring cognitive status. J Head Trauma Rehabil 2002; 17: 458—76.

16.

Erlanger D. , Feldman D. , Kutner K. , Kaushik T. , Kroger H. , Festa J. et al. Development and validation of a web-based neuropsychological test protocol for sports-related return-to-play decision-making . Arch Clin Neuropsychol 2003; 18: 293—316.

17.

Piras MR , Magnano I. , Canu ED , Paulus KS , Satta WM , Soddu A. et al. Longitudinal study of cognitive dysfunction in multiple sclerosis: neuropsychological, neuroradiological, and neurophysiological findings. J Neurol Neurosurg Psychiatry 2003; 74: 878—85.

18.

Barak A. , English N. Prospects and limitations of psychological testing on the Internet. Journal of Technology in Human Services 2002; 19: 65—89.

19.

Goverover Y. , Chiaravalloti N. , DeLuca J. The relationship between self-awareness of neurobehavioral symptoms, cognitive functioning, and emotional symptoms in multiple sclerosis. Mult Scler 2005; 11: 203—12.

20.

Benedict RH , Fischer JS , Archibald CJ , Arnett PA , Beatty WW , Bobholz J. et al. Minimal neuropsychological assessment of MS patients: a consensus approach. Clin Neuropsychol 2002; 16: 381—97.

21.

Benedict RH , Cookfair D. , Gavett R. , Gunther M. , Munschauer F. , Garg N. et al. Validity of the minimal assessment of cognitive function in multiple sclerosis (MACFIMS). J Int Neuropsychol Soc 2006; 12: 549—58.